Differences in survival from prostate cancer in Denmark, Iceland and Sweden

European Journal of Cancer

Volumn 49, Issue 8, 2013, Pages 1984-1992

  Brasso, Klaus ^a   Ingimarsdóttir, Inga Jóna ^b,c   Rusch, Ea ^c   Engholm, Gerda ^c   Adolfsson, Jan ^d   Tryggvadóttir, Laufey ^e,f   Jónsson, Eiríkur ^b   Bill Axelson, Anna ^g   Holmberg, Erik ^h   Storm, Hans Henrik ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e ICELANDIC CANCER REGISTRY   (Iceland)

^f UNIVERSITY OF ICELAND   (Iceland)

^g UPPSALA UNIVERSITY   (Sweden)

^h SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer register; Excess mortality rates; Incidence; Population based; Prostate cancer; Relative survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DENMARK; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL TIME; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DENMARK; HUMANS; ICELAND; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN; TIME FACTORS;

EID: 84876692946     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.01.008     Document Type: Article

References (32)

1. F. Bray, A. Klint, and M. Gislum Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006 Acta Oncol 49 5 2010 644 654
2. S. Tretli, A. Engeland, and T. Haldorsen Prostate cancer-look to Denmark? J Natl Cancer Inst 88 1996 28
3. A. Engeland, T. Haldorsen, and P.W. Dickman Relative survival of cancer patients-A comparison between Denmark and the other Nordic countries Acta Oncol 37 1 1998 49 59
4. M. Sant, C. Allemani, and M. Santaquilani EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary Eur J Cancer 45 6 2009 931 991
5. H.H. Storm, E.V. Michelsen, I.H. Clemmensen, and J. Pihl The Danish Cancer Registry-history, content, quality and use Dan Med Bull 44 5 1997 535 539
6. L.G. Sigurdardottir, J.G. Jonasson, and S. Stefansdottir Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness, and completeness Acta Oncol 51 2012 880 889
7. L. Barlow, K. Westergren, L. Holmberg, and M. Talback The completeness of the Swedish Cancer Register: a sample survey for year 1998 Acta Oncol 48 1 2009 27 33
8. J. Adolfsson, H. Garmo, and E. Varenhorst Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 Scand J Urol Nephrol 41 6 2007 456 477
9. L.H. Sobin, and C.H. Wittekind TNM classification of malignant tumors 6th ed. 2002 Wiley-Liss New York
10. F.K. Mostofi Grading of prostatic carcinoma Cancer Chemother Rep 59 1975 111 117
11. D.F. Gleason Classification of prostatic carcinomas Cancer Chemother Rep 50 3 1966 125 128
12. T. Hakulinen Cancer survival corrected for heterogeneity in patients withdrawal Biometrics 38 1982 933 942
13. G. Engholm, M. Gislum, F. Bray, and T. Hakulinen Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods Acta Oncol 49 5 2010 545 560
14. P.W. Dickman, A. Sloggett, M. Hills, and T. Hakulinen Regression models for relative survival Stat Med 23 1 2004 51 64 Available from: < http://www.pauldickman.com/rsmodels >
15. K. Brasso, and P. Iversen Prostatic cancer screening Ugeskr Laeger 164 2 2002 155 157
16. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 13 2009 1320 1328
17. E. Jonsson Prostate cancer and screening-to be or not to be Laeknabladid 95 6 2009 421
18. F. Bray, J. Lortet-Tieulent, J. Ferlam, D. Forman, and A. Auvinen Prostate cancer incidence and mortality in 37 European countries: an overview Eur J Cancer 46 2010 3040 3052
19. P.C. Albertsen, D.G. Fryback, B.E. Storer, T.F. Kolon, and J. Fine Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626 631
20. J. Adolfsson, L.-E. Rutquist, and G. Steineck Prostate carcinoma and long term survival Cancer 80 1997 748 752
21. G. Draisma, R. Boer, and S.J. Otto Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer J Natl Cancer Inst 95 12 2003 868 878
22. M. Borre, R. Erichsen, and L. Lund Survival of prostate cancer patients in central and northern Denmark, 1998-2009 Clin Epidemiol 3 Suppl. 1 2011 41 46
23. G.L. Lu-Yao, and S.L. Yao Population-based study of long-term survival in patients with clinically localised prostate cancer Lancet 349 1997 906 910
24. G.W. Chodak, R.A. Thisted, and G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242 248
25. P.C. Albertsen, J.A. Hanley, D. Gleason, and J.M. Barry Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer JAMA 280 1998 975 980
26. A. Bill-Axelson, L. Holmberg, and F. Filen Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial J Natl Cancer Inst 100 16 2008 1144 1154
27. A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 18 2011 1708 1717
28. P. Kupelian, M. Elshaikh, C. Reddy, C. Zippe, and E. Klein Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy J Clin Oncol 20 2002 3376 3385
29. P. Iversen, J.E. Johansson, and P. Lodding Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years Scand J Urol Nephrol 40 6 2006 441 452
30. P.C. Albertsen, J.A. Hanley, and G.H. Barrows Prostate cancer and the Will Rogers phenomenon J Natl Cancer Inst 97 17 2005 1248 1253
31. H.H. Storm, A.M. Kejs, and G. Engholm Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix Acta Oncol 49 5 2010 713 724
32. E. de Vries, I. Soerjomataram, S. Houterman, M.W. Louwman, and J.W.W. Coebergh Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol 165 2007 966 972